Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DocGo Inc. Director's Dealing 2022

Dec 20, 2022

33981_dirs_2022-12-19_d2e61d62-162a-405c-b67b-0e7450a370fb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DocGo Inc. (DCGO)
CIK: 0001822359
Period of Report: 2022-12-15

Reporting Person: ROSENBERG NORMAN (CFO (Ambulnz Holdings, LLC))

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-12-15 Options to purchase Common Stock $6.93 A 386579 Acquired 2032-12-15 Common Stock (386579) Direct

Footnotes

F1: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock.

F2: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 15, 2023 through December 15, 2026, in each case, subject to the terms of the Plan.